• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬蠕形螨病治疗的最新进展。

An update on the therapy of canine demodicosis.

作者信息

Mueller Ralf S

机构信息

Ludwig Maximilian University.

出版信息

Compend Contin Educ Vet. 2012 Apr;34(4):E1-4.

PMID:22488596
Abstract

Canine demodicosis, a disease caused by a proliferation of Demodex mites, typically leads to alopecia, comedones, follicular papules and pustules, scaling, and crusting. It may be treated with either amitraz rinses or macrocyclic lactones. Amitraz rinse is approved for application every 2 weeks at a concentration of 0.025%. Higher concentrations and more frequent applications increase the success rate but also increase the risk for adverse effects. Ivermectin is used at 0.3 to 0.6 mg/kg/d PO and moxidectin at 0.2 to 0.5 mg/kg/d PO. Both drugs may cause adverse neurologic effects in sensitive dogs. Milbemycin oxime at 1 to 2 mg/kg/d PO is a safer treatment option. A weekly spot-on combination of 2.5% moxidectin and 10% imidacloprid is recommended for milder forms of the disease.

摘要

犬蠕形螨病是一种由蠕形螨大量繁殖引起的疾病,通常会导致脱毛、粉刺、毛囊丘疹和脓疱、脱屑以及结痂。它可以用双甲脒冲洗液或大环内酯类药物治疗。双甲脒冲洗液被批准以0.025%的浓度每2周使用一次。更高的浓度和更频繁的使用会提高成功率,但也会增加不良反应的风险。伊维菌素的口服剂量为0.3至0.6毫克/千克/天,莫昔克丁的口服剂量为0.2至0.5毫克/千克/天。这两种药物都可能在敏感犬只中引起不良神经效应。口服剂量为1至2毫克/千克/天的米尔贝肟是一种更安全的治疗选择。对于病情较轻的犬蠕形螨病,建议每周使用一次含2.5%莫昔克丁和10%吡虫啉的滴剂组合。

相似文献

1
An update on the therapy of canine demodicosis.犬蠕形螨病治疗的最新进展。
Compend Contin Educ Vet. 2012 Apr;34(4):E1-4.
2
Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.用不同剂量的2.5%莫西菌素+10%吡虫啉滴剂和口服伊维菌素治疗犬全身性蠕形螨病:杀虫效果和长期治疗结果
Vet Parasitol. 2014 Oct 15;205(3-4):687-96. doi: 10.1016/j.vetpar.2014.08.021. Epub 2014 Sep 4.
3
Treatment protocols for demodicosis: an evidence-based review.蠕形螨病的治疗方案:一项基于证据的综述。
Vet Dermatol. 2004 Apr;15(2):75-89. doi: 10.1111/j.1365-3164.2004.00344.x.
4
Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.每月使用 10%莫昔克丁和 2.5%吡虫啉滴剂预防全身性蠕形螨病复发:一项初步研究。
Vet Rec. 2012 Sep 15;171(11):272. doi: 10.1136/vr.100843. Epub 2012 Jul 11.
5
Treatment of demodicosis in dogs: 2011 clinical practice guidelines.犬蠕形螨病的治疗:2011年临床实践指南
Vet Dermatol. 2012 Apr;23(2):86-96, e20-1. doi: 10.1111/j.1365-3164.2011.01026.x. Epub 2012 Feb 13.
6
Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.10%吡虫啉加2.5%莫昔克丁滴剂治疗犬全身性蠕形螨病的疗效和安全性评估:一项欧洲实地研究的结果
Parasitol Res. 2005 Oct;97 Suppl 1:S89-S96. doi: 10.1007/s00436-005-1450-3.
7
Treatment of naturally Notoedres cati-infested cats with a combination of imidacloprid 10 % / moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer).使用含有 10%吡虫啉/1%莫昔克丁的滴剂(Advocate/Advantage Multi,拜耳)对自然感染栉首蚤的猫进行联合治疗。
Parasitol Res. 2013 Aug;112 Suppl 1:57-66. doi: 10.1007/s00436-013-3281-y.
8
The main factors influencing canine demodicosis treatment outcome and determination of optimal therapy.影响犬蠕形螨病治疗效果及最佳治疗方案确定的主要因素。
Parasitol Res. 2015 Jul;114(7):2415-26. doi: 10.1007/s00436-015-4543-7. Epub 2015 May 28.
9
Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.犬全身性蠕形螨病的治疗:一项比较拜宠爽(拜耳动物保健公司)与伊维菌素疗效的盲法随机临床试验。
Vet Dermatol. 2009 Oct;20(5-6):447-55. doi: 10.1111/j.1365-3164.2009.00803.x.
10
A European field assessment of the efficacy of fluralaner (Bravecto) chewable and spot-on formulations for treatment of dogs with generalized demodicosis.一项关于氟雷拉纳(博来恩)咀嚼片和滴剂在治疗犬泛发性蠕形螨病中的疗效的欧洲现场评估。
Parasit Vectors. 2020 Jun 11;13(1):304. doi: 10.1186/s13071-020-04159-2.

引用本文的文献

1
toxicity of combination of amitraz and carvacrol on .双甲脒和香芹酚混合物对. 的毒性
Open Vet J. 2023 Jul;13(7):894-902. doi: 10.5455/OVJ.2023.v13.i7.11. Epub 2023 Jul 31.
2
Estimation of the prevalence and determination of risk factors associated with demodicosis in dogs.犬蠕形螨病患病率的估计及相关危险因素的确定。
J Adv Vet Anim Res. 2021 Mar 6;8(1):116-122. doi: 10.5455/javar.2021.h493. eCollection 2021 Mar.
3
Juvenile-onset and adult-onset demodicosis in dogs in the UK: prevalence and breed associations.英国犬类的幼年型和成年型蠕形螨病:患病率及品种关联
J Small Anim Pract. 2020 Jan;61(1):32-41. doi: 10.1111/jsap.13067. Epub 2019 Oct 4.
4
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.在欧洲的兽医皮肤科转诊中心中,两种阿福拉纳(NexGard®和 NexGard Spectra®)制剂治疗犬泛发性蠕形螨病的疗效。
Parasit Vectors. 2018 Sep 10;11(1):506. doi: 10.1186/s13071-018-3083-2.
5
Comparison of Diagnostic Methods and Sampling Sites for the Detection of Demodex musculi.检测猪蠕形螨的诊断方法与采样部位比较
J Am Assoc Lab Anim Sci. 2018 Mar 1;57(2):173-185.
6
Demodex musculi Infestation in Genetically Immunomodulated Mice.基因免疫调节小鼠中的毛囊蠕形螨感染
Comp Med. 2016;66(4):278-85.
7
Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.口服阿福拉纳治疗犬全身性蠕形螨病的疗效。
Parasite. 2016;23:14. doi: 10.1051/parasite/2016014. Epub 2016 Mar 24.
8
Digit loss due to Demodex spp. infestation in a dog: clinical and pathological features.一只狗因蠕形螨属感染导致的趾部缺失:临床和病理特征
Open Vet J. 2013;3(1):53-5. Epub 2013 May 20.
9
Efficacy of a topical application of Certifect® (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis.局部应用Certifect®(氟虫腈6.26% w/v、双甲脒7.48% w/v、(S)-烯虫酯5.63% w/v)治疗犬全身性蠕形螨病的疗效。
Parasite. 2013;20:46. doi: 10.1051/parasite/2013046. Epub 2013 Nov 21.